Takeda Pharmaceutical (TAK) Total Current Liabilities: 2018-2025
Historic Total Current Liabilities for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $16.5 billion.
- Takeda Pharmaceutical's Total Current Liabilities rose 5.26% to $16.4 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $16.4 billion, marking a year-over-year increase of 5.26%. This contributed to the annual value of $16.5 billion for FY2025, which is 2.59% up from last year.
- Per Takeda Pharmaceutical's latest filing, its Total Current Liabilities stood at $16.5 billion for FY2025, which was up 2.59% from $16.0 billion recorded in FY2024.
- In the past 5 years, Takeda Pharmaceutical's Total Current Liabilities registered a high of $19.1 billion during FY2022, and its lowest value of $16.0 billion during FY2024.
- For the 3-year period, Takeda Pharmaceutical's Total Current Liabilities averaged around $17.0 billion, with its median value being $16.5 billion (2025).
- In the last 5 years, Takeda Pharmaceutical's Total Current Liabilities declined by 16.45% in 2021 and then rose by 14.26% in 2022.
- Takeda Pharmaceutical's Total Current Liabilities (Yearly) stood at $16.7 billion in 2021, then rose by 14.26% to $19.1 billion in 2022, then decreased by 3.87% to $18.4 billion in 2023, then decreased by 12.70% to $16.0 billion in 2024, then increased by 2.59% to $16.5 billion in 2025.